Mostrar el registro sencillo del ítem

Using serological studies to assess COVID-19 infection fatality rate in developing countries: A case study from one Colombian department

dc.contributor.authorAlvis-Guzmán, Nelsonspa
dc.contributor.authorDE LA HOZ RESTREPO, FERNANDOspa
dc.contributor.authorSerrano Coll, Hectorspa
dc.contributor.authorGastelbondo, Bertha Irinaspa
dc.contributor.authorMATTAR, SALIMspa
dc.date.accessioned2021-08-19T16:22:27Z
dc.date.available2021-08-19T16:22:27Z
dc.date.issued2021
dc.identifier.issn12019712spa
dc.identifier.urihttps://hdl.handle.net/11323/8557spa
dc.description.abstractThis study describe the infection fatality rate (IFR) by COVID-19 by age groups in one department of Colombia. It used results from a serological survey to stablish a closer estimation of the true proportion of infected people. It found an overall IFR of 0.24% quite lower than the overall CFR (5.6%). We conclude that CFR severely overestimate the lethality of COVID-19 in developing areas.spa
dc.format.mimetypeapplication/pdfspa
dc.language.isospa
dc.rightsCC0 1.0 Universalspa
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/spa
dc.sourceInternational Journal of Infectious Diseasesspa
dc.subjectCase fatality ratespa
dc.subjectCOVID-19spa
dc.subjectdeveloping countriesspa
dc.subjectinfection fatality ratespa
dc.subjectlethalityspa
dc.subjectSARS COV 2spa
dc.titleUsing serological studies to assess COVID-19 infection fatality rate in developing countries: A case study from one Colombian departmentspa
dc.typeArtículo de revistaspa
dc.source.urlhttps://www.sciencedirect.com/science/article/pii/S1201971221005075spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.identifier.doi10.1016/j.ijid.2021.06.018spa
dc.identifier.instnameCorporación Universidad de la Costaspa
dc.identifier.reponameREDICUC - Repositorio CUCspa
dc.identifier.repourlhttps://repositorio.cuc.edu.co/spa
dc.relation.referencesInstituto Nacional de Salud (INS). Coronavirus Colombia [Cited 6 March 2021]. Available from: https://www.ins.gov.co/Noticias/paginas/coronavirus.aspx. 2021.spa
dc.relation.referencesHurtado-Ortiz A, Moreno-Montoya J, Prieto-Alvarado FE, Idrovo ÁJ. Evaluación comparativa de la vigilancia en salud pública de COVID-19 en Colombia: Primer semestre. Biomedica 2020;40(October (Suppl. 2))131–8 [Cited 6 March 2021]. Available from: https://revistabiomedica.org/index.php/biomedica/article/ view/5812.spa
dc.relation.referencesIoannidis JPA. Infection fatality rate of COVID-19 inferred from seroprevalence data. Bull World Health Organ 2021;99(1)19–33F World Health Organization. https:// doi.org/10.2471/BLT.20.265892.spa
dc.relation.referencesLevin AT, Hanage WP, Owusu-Boaitey N, Cochran KB, Walsh SP, Meyerowitz-Katz G. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. Eur J Epidemiol 2020;35:1123–38, doi:http://dx.doi.org/10.1007/s10654-020-00698-1 [Cited 22 March 2021]. Springer Science and Business Media B.V..spa
dc.relation.referencesMattar S, Alvis-Guzman N, Garay E, Rivero R, García A, Botero Y, et al. Severe Acute respiratory syndrome coronavirus 2 seroprevalence among adults in a Tropical City of the Caribbean Area, Colombia: are we much closer to herd immunity than developed countries?. Open Forum Infect Dis 2020;7(December (12)) [Cited 6 March 2021]. Available from: https://academic.oup.com/ofid/article/ doi/10.1093/ofid/ofaa550/5977863.spa
dc.relation.referencesMelnick ER, Ioannidis JPA. Should governments continue lockdown to slow the spread of covid-19?. BMJ 2020;369(June)m1924 [Cited March 2021]. Available from: https://www.spa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTspa
dc.type.versioninfo:eu-repo/semantics/acceptedVersionspa
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa


Ficheros en el ítem

Thumbnail
Nombre:
Using serological studies to ...
Tamaño:
263.7Kb
Formato:
PDF
Ver/
Thumbnail
Nombre:
license_rdf
Tamaño:
701bytes
Formato:
application/rdf+xml
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

  • Artículos científicos [3154]
    Artículos de investigación publicados por miembros de la comunidad universitaria.

Mostrar el registro sencillo del ítem

CC0 1.0 Universal
Excepto si se señala otra cosa, la licencia del ítem se describe como CC0 1.0 Universal